ARB trades at $0.14 with RSI at 23.39 showing extreme oversold conditions. Technical analysis suggests potential 79-100% recovery to $0.25-$0.28 range despite bearishARB trades at $0.14 with RSI at 23.39 showing extreme oversold conditions. Technical analysis suggests potential 79-100% recovery to $0.25-$0.28 range despite bearish

ARB Price Prediction: Targets $0.25-$0.28 Recovery by February End

5 min read

ARB Price Prediction: Targets $0.25-$0.28 Recovery by February End

Terrill Dicki Feb 03, 2026 11:22

ARB trades at $0.14 with RSI at 23.39 showing extreme oversold conditions. Technical analysis suggests potential 79-100% recovery to $0.25-$0.28 range despite bearish momentum.

ARB Price Prediction: Targets $0.25-$0.28 Recovery by February End

ARB Price Prediction Summary

Short-term target (1 week): $0.16-$0.17 • Medium-term forecast (1 month): $0.22-$0.28 range
Bullish breakout level: $0.17 (SMA 20 resistance) • Critical support: $0.13

What Crypto Analysts Are Saying About Arbitrum

Recent analyst coverage has painted a cautiously optimistic picture for Arbitrum despite current market weakness. Felix Pinkston noted on January 29th that "Arbitrum (ARB) trades at $0.16 with RSI at 30.74 suggesting oversold conditions. Analysts forecast 56-75% gains to $0.25-$0.28 range by February 2026 despite current bearish momentum."

Lawrence Jengar reinforced this sentiment on January 30th, observing that "Arbitrum (ARB) trades at $0.15 with RSI at oversold 27.93 levels, suggesting potential 47-65% recovery to analyst targets of $0.25-$0.28 range within weeks despite current bearish momentum."

Timothy Morano's January 28th analysis highlighted that "Arbitrum (ARB) trades at $0.17 with analyst targets of $0.25-$0.28 by February 2026. Technical indicators show oversold conditions with RSI at 34.03 signaling potential bounce."

The consensus among these analysts points toward a recovery scenario targeting the $0.25-$0.28 range, representing potential gains of 79-100% from current levels.

ARB Technical Analysis Breakdown

Arbitrum's current technical setup presents a compelling oversold condition that historically has led to meaningful rebounds. At $0.14, ARB is trading significantly below all major moving averages, with the 7-day SMA at $0.15, 20-day SMA at $0.17, and the critical 200-day SMA at $0.33.

The RSI reading of 23.39 indicates extreme oversold territory, marking one of the most attractive entry points from a momentum perspective. When RSI drops below 30, it typically signals that selling pressure has reached exhaustion levels, often preceding price reversals.

The MACD histogram at 0.0000 suggests that bearish momentum is flatlining, potentially signaling a transition phase. While the MACD line remains negative at -0.0169, the convergence toward zero could indicate weakening downward pressure.

Bollinger Bands analysis reveals ARB positioned at 0.11 on the band scale, placing it very close to the lower band at $0.12. This extreme positioning often coincides with oversold bounces, with the middle band at $0.17 serving as the initial recovery target.

The Stochastic oscillator shows both %K at 15.25 and %D at 12.20 in deeply oversold territory, reinforcing the RSI signal for potential reversal conditions.

Arbitrum Price Targets: Bull vs Bear Case

Bullish Scenario

In the bullish case for this ARB price prediction, a recovery toward $0.25-$0.28 appears technically feasible. The first major hurdle sits at the 7-day SMA of $0.15, followed by the critical 20-day SMA resistance at $0.17. Breaking above $0.17 would signal that the oversold bounce has legs and could target the 50-day SMA at $0.19.

The upper Bollinger Band at $0.22 represents a significant technical target, while analyst projections suggest extensions toward $0.25-$0.28 are possible if broader market conditions improve. A sustained move above $0.17 with increasing volume would confirm bullish momentum.

Key confirmation signals include RSI breaking back above 30, MACD histogram turning positive, and daily trading volume exceeding the current $11.37 million average.

Bearish Scenario

The bearish case for this Arbitrum forecast centers on the risk of breaking below the current support cluster around $0.13. While ARB has held this level, a breakdown could target the lower Bollinger Band at $0.12 or potentially extend toward psychological support at $0.10.

Risk factors include continued broader market weakness, potential selling pressure from long-term holders, and failure of the RSI to generate a meaningful bounce from oversold levels. The significant gap between current price and the 200-day SMA at $0.33 illustrates the depth of the current correction.

Should You Buy ARB? Entry Strategy

For traders considering this ARB price prediction, the current technical setup offers a compelling risk-reward ratio. Conservative entries could target the $0.13-$0.14 range with stop-losses placed below $0.12 to limit downside exposure.

More aggressive traders might consider dollar-cost averaging between current levels and $0.13 support, positioning for the potential recovery toward $0.17-$0.19. The oversold RSI condition suggests limited additional downside risk at current levels.

Risk management remains crucial given crypto market volatility. Consider position sizing that allows for potential drawdowns while maintaining exposure to the anticipated recovery. Setting partial profit targets at $0.16, $0.19, and $0.22 could help capture gains during the expected bounce.

Conclusion

This ARB price prediction suggests that Arbitrum presents one of the more compelling oversold opportunities in the current market. With RSI at 23.39 and analyst targets ranging from $0.25-$0.28, the risk-reward ratio appears favorable for patient investors.

The convergence of extreme oversold technical indicators and analyst consensus around February recovery targets supports a cautiously optimistic Arbitrum forecast. However, crypto markets remain highly volatile and unpredictable.

Disclaimer: Cryptocurrency investments carry substantial risk. This analysis is for informational purposes only and should not be considered financial advice. Always conduct your own research and consider your risk tolerance before investing.

Image source: Shutterstock
  • arb price analysis
  • arb price prediction
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29